Crescita Therapeutics (TSE:CTX) Sets New 12-Month High – What’s Next?

Shares of Crescita Therapeutics Inc. (TSE:CTX) hit a new 52-week high during trading on Wednesday . The company traded as high as C$0.76 and last traded at C$0.74, with a volume of 23519 shares traded. The stock had previously closed at C$0.75.

Crescita Therapeutics Price Performance

The company has a debt-to-equity ratio of 2.14, a quick ratio of 2.29 and a current ratio of 3.33. The company has a market cap of C$14.15 million, a P/E ratio of 37.50 and a beta of -1.55. The stock has a 50-day simple moving average of C$0.66 and a 200 day simple moving average of C$0.53.

Crescita Therapeutics (TSE:CTX) last posted its earnings results on Tuesday, March 31st. The company reported C($0.04) EPS for the quarter. The company had revenue of C$5.96 million for the quarter. Crescita Therapeutics had a negative return on equity of 0.59% and a negative net margin of 0.44%.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.